It is a business outsourcing private limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 | Mumbai, Maharashtra, India | ActiveNurexa Pharma Private Limited, a active private limited company, was established on 27 July 1995 in Mumbai, Maharashtra, India. Engaging in business & it consulting within the professional, scientific and technical sector, it holds CIN: U24230MH1995PTC091080. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.25 M.
Formerly known as Zydus Trading Company Private Limited. It upholds a compliant status. Its leadership includes Sameer Ashok Paigankar (Director), Suneela Ashok Paigankar (Director), Sheela Sameer Paigankar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3801, 38Th Floor, A Wing T 5,, Lodha Kiara, Pandurang Budkar Marg, Worli, Lower Parel, Mumbai, Maharashtra, 400013.
U24230MH1995PTC091080
091080
27 July 1995
₹1.00 M
₹0.25 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Nurexa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sameer Ashok Paigankar | Director | 16 May 2013 | Current |
| Suneela Ashok Paigankar | Director | 27 Jul 1995 | Current |
| Sheela Sameer Paigankar | Director | 28 Sep 1996 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nurexa Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 202.93% increase. The company also saw a substantial improvement in profitability, with a 191.1% increase in profit. The company's net worth Soared by an impressive increase of 18.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nurexa Pharma had a public holding of 0.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nurexa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nurexa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nurexa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nurexa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Nurexa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Sameer Ashok Paigankar was appointed as a Director was appointed as a Director on 16 May 2013 & has been associated with this company since 12 years 6 months . was completed.
The activity Sheela Sameer Paigankar was appointed as a Director was appointed as a Director on 28 Sep 1996 & has been associated with this company since 29 years 2 months . was completed.
The activity Suneela Ashok Paigankar was appointed as a Director was appointed as a Director on 27 Jul 1995 & has been associated with this company since 30 years 4 months . was completed.
Nurexa Pharma Private Limited was registered on 27 Jul 1995 with Roc Mumbai & aged 30 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Nurexa Pharma Private Limited is U24230MH1995PTC091080.
Nurexa Pharma Private Limited is headquartered at 3801, 38Th Floor, A Wing T 5,, Lodha Kiara, Pandurang Budkar Marg, Worli, Lower Parel, Mumbai, Maharashtra, 400013.
Nurexa Pharma Private Limited was incorporated on 27 July 1995.
The current directors of Nurexa Pharma Private Limited are
The primary industry of Nurexa Pharma Private Limited is Professional, Scientific And Technical.
Nurexa Pharma Private Limited is unlisted.
The authorized capital of Nurexa Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.25 M.
The compliance status of Nurexa Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX